QuickView for Ku, C-terminal (biogroup)

1. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
2. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
3. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
4. L1000 CMAP - Neuroblastoma SH-SY5Y cells with shRNA-mediated gene knockdown
5. L1000 CMAP - Embryonic kidney 293T cells with shRNA-mediated gene knockdown

There were no matches for Ku, C-terminal

1. Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HI…
2. A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified N…
3. MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metasta…
4. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 2013…
5. A Study of AZD8233 in Participants With Dyslipidemia.